BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 10453417)

  • 1. Development of a transgenic mouse model using rat insulin promoter to drive the expression of CRE recombinase in a tissue-specific manner.
    Ray MK; Fagan SP; Moldovan S; DeMayo FJ; Brunicardi FC
    Int J Pancreatol; 1999 Jun; 25(3):157-63. PubMed ID: 10453417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta cell-specific ablation of target gene using Cre-loxP system in transgenic mice.
    Ray MK; Fagan SP; Moldovan S; DeMayo FJ; Brunicardi FC
    J Surg Res; 1999 Jun; 84(2):199-203. PubMed ID: 10357920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mouse model for beta cell-specific ablation of target gene(s) using the Cre-loxP system.
    Ray MK; Fagan SP; Moldovan S; DeMayo FJ; Brunicardi FC
    Biochem Biophys Res Commun; 1998 Dec; 253(1):65-9. PubMed ID: 9875221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A transgenic mouse that targets the expression of Cre recombinase in pancreatic tissue.
    Zhou J; Cheng X; Lu YX; Huang CF; Yang X
    Sheng Wu Gong Cheng Xue Bao; 2002 May; 18(3):286-90. PubMed ID: 12192858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Cre-loxP system: a versatile tool for targeting genes in a cell- and stage-specific manner.
    Ray MK; Fagan SP; Brunicardi FC
    Cell Transplant; 2000; 9(6):805-15. PubMed ID: 11202567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse alpha1(I)-collagen promoter is the best known promoter to drive efficient Cre recombinase expression in osteoblast.
    Dacquin R; Starbuck M; Schinke T; Karsenty G
    Dev Dyn; 2002 Jun; 224(2):245-51. PubMed ID: 12112477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A transgenic mouse that targets the expression of Cre recombinase in hepatocyte].
    Wang YL; Cheng X; Cui F; Cheng J; Lü YX; Yang X
    Zhonghua Gan Zang Bing Za Zhi; 2004 Mar; 12(3):163-6. PubMed ID: 15059303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transgenic mouse with high Cre recombinase activity in all prostate lobes, seminal vesicle, and ductus deferens.
    Jin C; McKeehan K; Wang F
    Prostate; 2003 Oct; 57(2):160-4. PubMed ID: 12949940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RIP-Cre revisited, evidence for impairments of pancreatic beta-cell function.
    Lee JY; Ristow M; Lin X; White MF; Magnuson MA; Hennighausen L
    J Biol Chem; 2006 Feb; 281(5):2649-53. PubMed ID: 16326700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelium-specific Cre recombinase activity in flk-1-Cre transgenic mice.
    Licht AH; Raab S; Hofmann U; Breier G
    Dev Dyn; 2004 Feb; 229(2):312-8. PubMed ID: 14745955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations of pancreatic beta-cell mass and islet number due to Ins2-controlled expression of Cre recombinase: RIP-Cre revisited; part 2.
    Pomplun D; Florian S; Schulz T; Pfeiffer AF; Ristow M
    Horm Metab Res; 2007 May; 39(5):336-40. PubMed ID: 17533574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bypass of lethality with mosaic mice generated by Cre-loxP-mediated recombination.
    Betz UA; Vosshenrich CA; Rajewsky K; Müller W
    Curr Biol; 1996 Oct; 6(10):1307-16. PubMed ID: 8939573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain expression of Cre recombinase driven by pancreas-specific promoters.
    Song J; Xu Y; Hu X; Choi B; Tong Q
    Genesis; 2010 Nov; 48(11):628-34. PubMed ID: 20824628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased Specific Labeling of INS-1 Pancreatic Beta-Cell by Using RIP-Driven Cre Mutants with Reduced Activity.
    Gong GC; Fan WZ; Li DZ; Tian X; Chen SJ; Fu YC; Xu WC; Wei CJ
    PLoS One; 2015; 10(6):e0129092. PubMed ID: 26046525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of mice expressing Ins1 gene promoter driven CreERT recombinase for conditional gene deletion in pancreatic β-cells.
    Tamarina NA; Roe MW; Philipson L
    Islets; 2014; 6(1):e27685. PubMed ID: 25483876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generating Beta-Cell-Specific Transgenic Mice Using the Cre-Lox System.
    Smith LIF; Hill TG; Bowe JE
    Methods Mol Biol; 2020; 2128():181-205. PubMed ID: 32180194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse opsin promoter-directed Cre recombinase expression in transgenic mice.
    Le YZ; Zheng L; Zheng W; Ash JD; Agbaga MP; Zhu M; Anderson RE
    Mol Vis; 2006 Apr; 12():389-98. PubMed ID: 16636658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Site-specific recombination of a transgene in fertilized eggs by transient expression of Cre recombinase.
    Araki K; Araki M; Miyazaki J; Vassalli P
    Proc Natl Acad Sci U S A; 1995 Jan; 92(1):160-4. PubMed ID: 7816809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of a prostate epithelial cell-specific Cre transgenic mouse model for tissue-specific gene ablation.
    Wu X; Wu J; Huang J; Powell WC; Zhang J; Matusik RJ; Sangiorgi FO; Maxson RE; Sucov HM; Roy-Burman P
    Mech Dev; 2001 Mar; 101(1-2):61-9. PubMed ID: 11231059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific Cre/Lox recombination in the mouse proximal tubule.
    Rubera I; Poujeol C; Bertin G; Hasseine L; Counillon L; Poujeol P; Tauc M
    J Am Soc Nephrol; 2004 Aug; 15(8):2050-6. PubMed ID: 15284291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.